Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurementSilvia Spena, Bülent Zülfikar, P.M. Mannucci et al.|Journal of Thrombosis and Haemostasis|2018Cited by 33
High treatment compliance and tolerability with fitusiran antithrombin-based dose regimen in people with hemophilia A or B, with or without inhibitors: ATLAS-OLE studyMindy Simpson, Erin Cockrell, Chia-Yau Chang et al.|Blood|2025Cited by 0